BeiGene Market Cap

BeiGene has a market cap or net worth of 192.33 billion as of April 28, 2025. Its market cap has increased by 69.89% in one year.

Market Cap

192.33B

Enterprise Value

181.05B

Revenue

27.81B

Ranking

n/a

PE Ratio

n/a

Stock Price

247.21

Market Cap Chart

Since February 3, 2016, BeiGene's market cap has increased from 5.65B to 192.33B, an increase of 3,304.84%. That is a compound annual growth rate of 46.55%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2025	192.33B	33.98%
Dec 31, 2024	143.55B	7.76%
Dec 29, 2023	133.21B	-15.45%
Dec 30, 2022	157.55B	-10.93%
Dec 31, 2021	176.88B	15.32%
Dec 31, 2020	153.38B	117.37%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	319.64B
Shenzhen Mindray Bio-Medical Electronics	262.45B
WuXi AppTec	163.06B
Zhangzhou Pientzehuang Pharmaceutical.,	124.34B
Aier Eye Hospital Group	121.89B
Sichuan Biokin Pharmaceutical	111.04B
Shanghai United Imaging Healthcare	104.35B
Yunnan Baiyao Group Co.,Ltd	103.31B

Market Cap Rankings